Application no. and date | 17786774.4 (espacenet) (Federated) (European Patent Register), 20170421 | Patent/reg. no. and date | DK/EP 3445368, 20240717 | Publication date | 20190227 | Priority no. and date | US 201662325860 P, 20160421 | EP pub. no. and date |
EP 3445368 20190227 | Effective date | | Applicant/owner | The U.S.A. As Represented By The Secretary, Department Of Health And Human Services, National Institues of Health 6011 Executive Boulevard Suite 325 MSC 7660
Bethesda, MD 20892-7660, US, Board of Regents, The University of Texas System, 210 West 7th Street
Austin, TX 78701, US, Astrocyte Pharmaceuticals, Inc., 245 First Street Suite 1800
Cambridge, Massachusetts 02142, US | Applicant ref. no. | | Inventor | JACOBSON, Kenneth A., 11218 Watermill Lane
Silver Spring Maryland 20902, US, KORINEK, William S., 163 Long Wharf Drive
Mystic Connecticut 06355, US, LECHLEITER, James D., 112 Martha Glynn Court
San Antonio Texas 78213, US, LISTON, Theodore E., 33 Kidds Way
Stonington Connecticut 06378, US | Representative | | Opponent | | IPC Class | A61K 31/519 (2006.01) , A61K 31/52 (2006.01) , A61K 31/7076 (2006.01) , A61P 25/00 (2006.01) , A61P 9/00 (2006.01) | Title | COMPOUNDS AND METHODS FOR TREATING NEUROLOGICAL AND CARDIOVASCULAR CONDITIONS | Int. application no. | US2017028996 | Int. publication no. | WO2017185061 | Related patent (certificate) | | Status | Enhedspatent registreret | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|